No Data
No Data
Express News | Soligenix Will Be Issued U.S. Patent Number 12,097,291 Tomorrow Titled "Thermostable Vaccine Compositions And Methods Of Preparing Same"
Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing
Soligenix Receives European Patent Titled 'Systems and Methods for Producing Synthetic Hypericin'
Express News | Soligenix Receives European Patent for Improved Production of Synthetic Hypericin
Express News | Soligenix Inc - Entered Into at Market Issuance Sales Agreement
No Data
No Data